2026 Q3 Portfolio Activity
In 2026 Q3, B Group, Inc. maintained a portfolio of 20 distinct positions. The most significant new addition was Q32 BIO INC, now representing 0.33% of the total fund value. They heavily accumulated shares in BRIGHT MINDS BIOSCIENCES INC, increasing the position by 40.7%. Conversely, B Group, Inc. completely exited their position in INVESCO QQQ TR.
Position History
hover any row below to update
Loading…
Total Positions
20
Quarter
2026 Q3
Top Holding
ADMA (20.2%)
Top 10 Concentration
80.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-20 of 20
B Group, Inc. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 20.18% | 12.82% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
3,262,542 | $32,723,296 |
$15.10
-9.7%
|
2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
SNSE
FAETH THERAPEUT...
|
Healthcare | 11.19% | 7.16% |
#2
3
Prev: #5
|
6.5 |
—
|
no change | no change |
P
S
|
610,169 | $18,146,426 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 9.50% | 11.20% |
#3
Prev: #3
|
5.8 |
—
|
no change | no change |
P
S
|
11,414,285 | $15,409,285 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NRXP
NRX PHARMACEUTI...
|
Healthcare | 7.70% | 7.86% |
#4
Prev: #4
|
4.1 |
—
|
185,433 | 4.5% |
P
S
|
4,277,200 | $12,489,424 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 7.32% | 4.02% |
#5
4
Prev: #9
|
4.4 |
—
|
no change | no change |
P
S
|
450,646 | $11,870,016 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 5.97% | 5.22% |
#6
1
Prev: #7
|
3.4 |
—
|
no change | no change |
P
S
|
33,237 | $9,679,612 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SGHT
SIGHT SCIENCES ...
|
Healthcare | 5.60% | 1.72% |
#7
11
Prev: #18
|
3.2 |
—
|
no change | no change |
P
S
|
970,000 | $9,079,200 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 5.41% | 5.76% |
#8
2
Prev: #6
|
3.2 |
—
|
no change | no change |
P
S
|
1,800,556 | $8,768,708 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IOVA
IOVANCE BIOTHER...
|
Healthcare | 3.88% | 2.93% |
#9
3
Prev: #12
|
1.6 |
—
|
-1,075,000 | -71.7% |
P
S
|
425,000 | $6,298,500 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 3.47% | 3.53% |
#10
Prev: #10
|
3.9 |
—
|
40,000 | 28.6% |
P
S
|
180,000 | $5,628,600 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 3.43% | 2.92% |
#11
2
Prev: #13
|
1.9 |
—
|
-7,500 | -10.7% |
P
S
|
62,500 | $5,564,375 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLLS
CELLECTIS S A
|
Healthcare | 3.06% | 4.62% |
#12
4
Prev: #8
|
2.2 |
—
|
no change | no change |
P
S
|
3,281,501 | $4,955,067 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 2.96% | 2.55% |
#13
1
Prev: #14
|
2.2 |
—
|
no change | no change |
P
S
|
764,243 | $4,799,446 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 2.92% | 2.22% |
#14
2
Prev: #16
|
3.7 |
—
|
27,500 | 40.7% |
P
S
|
95,000 | $4,732,900 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 2.83% | 3.35% |
#15
4
Prev: #11
|
1.1 |
—
|
-20,000 | -26.7% |
P
S
|
55,000 | $4,580,950 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 2.55% | 2.27% |
#16
1
Prev: #15
|
2.0 |
—
|
no change | no change |
P
S
|
175,706 | $4,127,334 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.25% | 2.12% |
#17
Prev: #17
|
1.5 |
—
|
no change | no change |
P
S
|
135,000 | $2,029,050 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FHTX
FOGHORN THERAPE...
|
Healthcare | 0.44% | 0.46% |
#18
1
Prev: #19
|
1.2 |
—
|
no change | no change |
P
S
|
200,000 | $714,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.33% | — |
#19
Prev: #—
|
3.6 |
—
|
65,000 | — |
NEW
|
65,000 | $537,550 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
PUT
INVESCO QQQ TR
|
|
PUT Option | 0.00% | 17.29% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-50,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-20 of 20 holdings